Download Files:
Products Details
Product Description
– RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1].
Web ID
– HY-143545
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C27H30N6O3
References
– [1]Gou J, et, al. Pyrazole[1,5-a]pyridine-3-nitrile compound and pharmaceutical use thereof. WO2021093720A1.
CAS Number
– 2642164-75-6
Molecular Weight
– 486.57
SMILES
– N#CC1=C2C(C3=CC=C(N4CCN(C([C@H](O)C(C)C)=O)CC4)N=C3)=CC(C5=CCOCC5)=CN2N=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– RET
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
